Your browser doesn't support javascript.
loading
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.
LeRoith, Derek; Biessels, Geert Jan; Braithwaite, Susan S; Casanueva, Felipe F; Draznin, Boris; Halter, Jeffrey B; Hirsch, Irl B; McDonnell, Marie E; Molitch, Mark E; Murad, M Hassan; Sinclair, Alan J.
Afiliação
  • LeRoith D; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Biessels GJ; University Medical Center Utrecht, Utrecht, Netherlands.
  • Braithwaite SS; Presence Saint Francis Hospital, Evanston, Illinois.
  • Casanueva FF; Presence Saint Joseph Hospital, Chicago, Illinois.
  • Draznin B; Complejo Hospitalario Universitario de Santiago, CIBER de Fisiopatologia Obesidad y Nutricion, Instituto Salud Carlos III, Santiago de Compostela, Spain.
  • Halter JB; University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado.
  • Hirsch IB; University of Michigan, Ann Arbor, Michigan.
  • McDonnell ME; National University of Singapore, Singapore, Singapore.
  • Molitch ME; University of Washington Medical Center-Roosevelt, Seattle, Washington.
  • Murad MH; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Sinclair AJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
J Clin Endocrinol Metab ; 104(5): 1520-1574, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30903688
OBJECTIVE: The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. CONCLUSIONS: Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Complicações do Diabetes / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Estilo de Vida Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Aged / Aged80 / Humans Idioma: En Revista: J clin endocrinol metab Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Complicações do Diabetes / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Estilo de Vida Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Aged / Aged80 / Humans Idioma: En Revista: J clin endocrinol metab Ano de publicação: 2019 Tipo de documento: Article